← All trials
NCT02908906
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 21, 2016
- Primary completion
- Apr 30, 2019
- Completion date
- Jul 18, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 169
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Johnson and JohnsonLead sponsor
- Johnson and JohnsonStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.